The Oxford-AstraZeneca Covid-19 vaccine candidate shows a strong immune response in adults in their 60s and 70s, according to researchers, raising hopes that it can protect age groups most at risk from the virus. Three vaccines – Pfizer-BioNTech, Sputnik and Moderna – have already reported good preliminary data from phase three trials, with one suggesting 94% of people over 65 could be protected from Covid-19
also read Gujarat: Complete curfew in Ahmedabad city during weekend from 9 pm to curb rising Corona cases
also read Backend code of Aarogya Setu App released to enhance transparency